Healios KK

TSE:4593 (Japan)  
円 146.00 (+1.39%) May 20
At Loss
P/B:
3.56
Market Cap:
円 13.16B ($ 84.19M)
Enterprise V:
円 9.29B ($ 59.44M)
Volume:
302.00K
Avg Vol (2M):
1.53M
Warning! GuruFocus detected 3 Severe warning signs with 4593. Try a 7-Day Free Trial to check it out.
Also Trade In:
Volume:
302.00K
Market Cap 円:
13.16B
Market Cap $:
84.19M
At Loss
Avg Vol (2M):
1.53M
Enterprise Value 円:
9.29B
Enterprise Value $:
59.44M
PB Ratio:
3.56
Alerts Website Sources Stock PDF
Dataset
Financial Download P  Manual of Stocks™

Business Description

Healios KK

ISIN : JP3835100003
https://www.healios.co.jp
World Trade Center Bldg. 15th Floor, 2-4-1 Hamamatsucho, Minato-ku, Tokyo, JPN, 105-6115
Compare
Compare
TSE:4894TSE:4572TSE:4571TSE:2183TSE:3750TSE:2370TSE:4891TSE:7776TSE:4579TSE:4598OCSE:NOVO BVRTXREGNASX:CSLSGENXKRX:207940MRNAHKSE:02269XBRU:ARGXBNTX
Traded in other countries / regions
4593.JapanHLOSF.USA6VX.Germany
IPO Date
2015-06-16
Description
Healios KK is involved in development and sales of opthalmological surgery adjuvants and research, development and manufacture of cell therapy products and regenerative medicine products. The company is developing treatments for age-related macular degeneration and organ anlage transplantation therapy.

Financial Strength

2/10
Name Current Vs Industry Vs History
Cash-To-Debt 1.86
Equity-to-Asset 0.22
Debt-to-Equity 1.22
Debt-to-EBITDA -1.67
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.13
Distress
Grey
Safe
Beneish M-Score -2.9
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 50.2
3-Year EBITDA Growth Rate 19.9
3-Year EPS without NRI Growth Rate 19.4
3-Year FCF Growth Rate 20.3
3-Year Book Growth Rate -30.2

Momentum Rank

2/10
Name Current Vs Industry Vs History
5-Day RSI 40.27
9-Day RSI 42.06
14-Day RSI 45.19
6-1 Month Momentum % -11.59
12-1 Month Momentum % -52.77

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.34
Quick Ratio 1.34
Cash Ratio 1.23
Days Sales Outstanding 695.27
Days Payable 7227

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -13
Shareholder Yield % -20.14

Profitability Rank

1/10
Name Current Vs Industry Vs History
Gross Margin % 90.32
Operating Margin % -2855.65
Net Margin % -4447.58
FCF Margin % -2250
ROE % -136.16
ROA % -34.69
ROIC % -29.37
ROC (Joel Greenblatt) % -274.35
ROCE % -27.84

GF Value Rank

2/10
Name Current Vs Industry Vs History
PS Ratio 77.45
PB Ratio 3.56
EV-to-EBIT -3.16
EV-to-EBITDA -3.43
EV-to-Revenue 74.92
EV-to-FCF -3.27
Earnings Yield (Greenblatt) % -31.63
FCF Yield % -21.21

Financials

TSE:4593's 30-Y Financials
AAPL
Income Statement Breakdown FY
No Enough Data
AAPL
Balance Sheet Breakdown
No Enough Data
AAPL
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Healios KK Executives

Details

GF Value: 円1695.51

TSE:4593

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil 円) 124
EPS (TTM) (円) -73.84
Beta 0.9
Volatility % 40.64
14-Day RSI 45.19
14-Day ATR (円) 6.472111
20-Day SMA (円) 149.45
12-1 Month Momentum % -52.77
52-Week Range (円) 114 - 332
Shares Outstanding (Mil) 90.13

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Healios KK Filings

Filing Date Document Date Form
No Filing Data

Healios KK Stock Events

Financials Calendars
Event Date Price(円)
No Event Data

Healios KK Frequently Asked Questions

What is Healios KK(TSE:4593)'s stock price today?
The current price of TSE:4593 is 円146.00. The 52 week high of TSE:4593 is 円332.00 and 52 week low is 円114.00.
When is next earnings date of Healios KK(TSE:4593)?
The next earnings date of Healios KK(TSE:4593) is .
Does Healios KK(TSE:4593) pay dividends? If so, how much?
Healios KK(TSE:4593) does not pay dividend.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.